Skip to main content

Table 1 DNA prevalence of HPyV6 and HPyV7 in different patient groups

From: HPyV6 and HPyV7 in urine from immunocompromised patients

Patient group (n) HPyV6 (%) HPyV7 (%)
SLE (5)
 SLE1 (5 samples) 1 (20.0) 0 (0)
 SLE2 (7 samples) 1 (14.3) 0 (0)
 SLE3 (13 samples) 4 (30.8) 2 (15.4)a
 SLE4 (16 samples) 4 (25.0) 3 (18.8)b
 SLE5 (32 samples) 11 (34.4) 1 (3.1)c
 Total samples (73) 21 (28.8) 6 (8.2)
Multiple sclerosis (30) 0 (0) 0 (0)
Psoriasis vulgaris (15) 0 (0) 0 (0)
Arthritic psoriasis (15) 0 (0) 0 (0)
HIV-positive (66) 6 (9.1) 0 (0)
Pregnant women (47) 19 (40.4) 4 (8.5)d
Blood donors (20) 0 (0) 0 (0)
  1. aThese samples were also HPyV6 positive
  2. bOne sample was also HPyV6 positive
  3. cThis sample was also HPyV6 positive
  4. dTwo samples were also positive for HPyV6
\